Related references
Note: Only part of the references are listed.Clinical Significance of Guanylate Cyclase Stimulator, Riociguat, on Right Ventricular Functional Improvement in Patients with Pulmonary Hypertension
Mitsushige Murata et al.
CARDIOLOGY (2021)
Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension
Roberto Badagliacca et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Raymond L. Benza et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)
Echocardiographic Assessment of Right Ventricular-Arterial Coupling in Predicting Prognosis of Pulmonary Arterial Hypertension Patients
Remigiusz Kazimierczyk et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension
Mizuki Momoi et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2021)
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
Michele D'Alto et al.
CHEST (2020)
Long-term changes of right ventricular myocardial deformation and remodeling studied by cardiac magnetic resonance imaging in patients with chronic thromboembolic pulmonary hypertension following pulmonary thromboendarterectomy
Farhad Waziri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE
Raymond L. Benza et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Usefulness of Adding Echocardiography of the Right Heart to Risk-Assessment Scores in Prostanoid-Treated Pulmonary Arterial Hypertension
Roberto Badagliacca et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Limitations of right ventricular annular parameters in the early postoperative period following pulmonary endarterectomy: an observational study
Saida Rezaiguia-Delclaux et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2020)
Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension
Qin-Hua Zhao et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2020)
Improvements of right ventricular function and hemodynamics after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Batur Gonenc Kanar et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2019)
Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients
Christian Schoenfeld et al.
EUROPEAN RADIOLOGY (2019)
Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
Anton Vonk Noordegraaf et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
Jing-Hui Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
MRI-derived Regional Biventricular Function in Patients with Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Endarterectomy
Sabine K. Maschke et al.
ACADEMIC RADIOLOGY (2018)
Effects of Riociguat on Right Ventricular Remodelling in Chronic Thromboembolic Pulmonary Hypertension Patients: A Prospective Study
Ali Ahmadi et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension
Yoshihiro Kamimura et al.
HEART AND VESSELS (2018)
Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics
Darocha Szymon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart Function
R. L. Benza et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension
Roberto Badagliacca et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension
Roberto Badagliacca et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension
Jason Weatherald et al.
CIRCULATION (2018)
Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular-Pulmonary Arterial Coupling
Irina N. Taran et al.
LUNG (2018)
Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study
Lukas Fischer et al.
RESPIRATORY RESEARCH (2018)
The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study
Takahiro Sato et al.
PULMONARY CIRCULATION (2018)
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Alberto M. Marra et al.
RESPIRATORY RESEARCH (2018)
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
Nick H. Kim et al.
HEART (2017)
A Comparison of Echocardiographic Variables of Right Ventricular Function with Exercise Capacity After Bosentan Treatment in Patients with Pulmonary Arterial Hypertension: Results from a Multicenter, Prospective, Cohort Study
Hyungseop Kim et al.
JOURNAL OF CLINICAL ULTRASOUND (2017)
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension
Stefano Ghio et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Comparison of hemodynamic parameters in treatment-naive and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study
Nazzareno Gabe et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension
Anton Vonk Noordegraaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
Peter Sandner et al.
RESPIRATORY MEDICINE (2017)
Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension
Mitsushige Murata et al.
PULMONARY CIRCULATION (2017)
The overloaded right heart and ventricular interdependence
Robert Naeije et al.
CARDIOVASCULAR RESEARCH (2017)
The pathophysiology of chronic thromboembolic pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Riociguat: Mode of Action and Clinical Development in Pulmonary Hypertension
Hossein-Ardeschir Ghofrani et al.
CHEST (2017)
Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice
Kabita Pradhan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Changes in surface electrocardiogram in patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy. Correlations with hemodynamic and echocardiographic improvements after surgery
Stefano Ghio et al.
JOURNAL OF ELECTROCARDIOLOGY (2016)
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension
Roberto Badagliacca et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Echocardiographic evidence of right ventricular functional improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
Kaspar Broch et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Significance of Echocardiographic Assessment for Right Ventricular Function After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Induced Pulmonary Hypertension
Toshimitsu Tsugu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension
Guido Claessen et al.
HEART (2015)
Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Alberto M. Marra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology
Roberto Badagliacca et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension
Rebecca R. Vanderpool et al.
HEART (2015)
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension
Andrea Frustaci et al.
AIDS (2014)
Stimulation of Soluble Guanylate Cyclase Prevents Cigarette Smoke-induced Pulmonary Hypertension and Emphysema
Norbert Weissmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Right ventricular reverse remodelling after balloon pulmonary angioplasty
Shigefumi Fukui et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Right ventricular longitudinal deformation parameters and exercise capacity Prognosis of patients with chronic thromboembolic pulmonary hypertension
M. Sunbul et al.
HERZ (2014)
Right ventricular reverse remodeling after pulmonary endarterectomy: magnetic resonance imaging and clinical and right heart catheterization assessment
Marius Berman et al.
PULMONARY CIRCULATION (2014)
Effects of Inhaled Iloprost on Exercise Capacity, Quality of Life, and Cardiac Function in Patients With Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease (the Eisenmenger Syndrome) (from the EIGER Study)
Kwang Soo Cha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Bosentan Treatment Is Associated With Improvement of Right Ventricular Function and Remodeling in Chronic Thromboembolic Pulmonary Hypertension
Sulaiman Surie et al.
CLINICAL CARDIOLOGY (2013)
Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension
Friedrich C. Blumberg et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Right Heart Adaptation to Pulmonary Arterial Hypertension Physiology and Pathobiology
Anton Vonk-Noordegraaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
Michaela Lang et al.
PLOS ONE (2012)
Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy
Marielle C. van de Veerdonk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis
Oleg V Evgenov et al.
BMC Pharmacology & Toxicology (2011)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Maria J. Overbeek et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2010)
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension.
Stephen L. Archer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation
Anna R. Hemnes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
R. T. Schermuly et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility
Jayan Nagendran et al.
CIRCULATION (2007)
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients
C. Tji-Joong Gan et al.
CHEST (2007)
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
Serge A. van Wolferen et al.
EUROPEAN HEART JOURNAL (2007)
Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study
MR Wilkins et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Echo cardiographic predictors of adverse outcomes in primary pulmonary hypertension
RJ Raymond et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
